Research Preprints: Pharma’s Slow Embrace And Predicament
Pandemic Highlights Multiple Issues
Executive Summary
Pharma appears to be treading carefully when it comes to research preprints but COVID-19 has spotlighted the role of these pre-peer-reviewed papers during public health emergencies.